MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (indian pharma)
- PIRAMAL ENTERPRISES
PIRAMAL ENTERPRISES Share Price (NCHP)
Here is the latest stock price and chart of Piramal Healthcare. For more details, see the Piramal Healthcare company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
| Live BSE Quotes | Oct 22, 2019 (Close) | ||
|---|---|---|---|
| Price (Rs)1,680.50 | Open (Rs) 1,588.70 | High (Rs) 1,723.50 | Low (Rs) 1,584.75 |
| % Change7.98 | Volume 239,390 | Value (Rs) 401,137,822 | 52-Week H/L 2,795.95 / 1,302.00 |
| Live NSE Quotes | Oct 22, 2019 (Close) | ||
|---|---|---|---|
| Price (Rs)1,680.40 | Open (Rs) 1,582.00 | High (Rs) 1,723.00 | Low (Rs) 1,582.00 |
| % Change7.94 | Volume 3,995,489 | Value (Rs) 6,692,757,556 | 52-Week H/L 2,787.70 / 1,316.00 |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 100.33 | P/E Ratio (x) 16.75 | Market Cap (Rs m) 289,987.08 | P/BV (x) 1.06 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
PIRAMAL ENTERPRISES Share Price Today:
PIRAMAL ENTERPRISES last traded price had surged 8.0% to Rs 1,680.5 on the BSE. On the NSE, PIRAMAL ENTERPRISES last traded price had surged 7.9% to Rs 1,680.4. The total volume of shares traded was 4.2 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.6%. And the benchmark S&P BSE SENSEX was at 38,963.8 (down 0.9%).
Over the last 30 days, the PIRAMAL ENTERPRISES share price is down 9.0%. And over the last one year, PIRAMAL ENTERPRISES share price is down 11.1%.
|
| |
Today's Market
Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)
India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).
Related Views On News
PIRAMAL ENTERPRISES Surges by 10%; BSE HEALTHCARE Index Up 1.3% (Market Updates)
Oct 22, 2019 | Updated on Oct 22, 2019PIRAMAL ENTERPRISES share price has surged by 10% and its current market price is Rs 1,712. The BSE HEALTHCARE is up by 1.3%. The top gainers in the BSE HEALTHCARE Index is PIRAMAL ENTERPRISES (up 10.0%). The top losers are BIOCON (down 0.3%) and ALKEM LABORATORIES (down 0.3%).
ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 1.2% (Market Updates)
Oct 22, 2019 | Updated on Oct 22, 2019ASTRAZENECA PHARMA share price has surged by 5% and its current market price is Rs 2,424. The BSE HEALTHCARE is up by 1.2%. The top gainers in the BSE HEALTHCARE Index are ASTRAZENECA PHARMA (up 5.5%) and PIRAMAL ENTERPRISES (up 7.2%). The top losers are GLENMARK PHARMA (down 0.2%) and SANOFI INDIA (down 0.2%).
PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)
Aug 1, 2019 | Updated on Aug 1, 2019For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.
PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)
Jul 9, 2019 | Updated on Jul 9, 2019Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.
PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)
Apr 30, 2019 | Updated on Apr 30, 2019For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.
More Views on NewsMost Popular
My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)
Oct 14, 2019This is once in a decade opportunity to make a killing from smallcap rebound.
Buy these 3 Stocks for Rebound Riches
Oct 18, 2019Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...
Two Stocks to Buy in the Great Indian Festival (Profit Hunter)
Oct 11, 2019Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.
The One Stock I Like in this Market (The 5 Minute Wrapup)
Oct 10, 2019There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?
5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)
Oct 11, 2019Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.
MoreTRACK PIRAMAL ENTERPRISES
- Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON PIRAMAL ENTERPRISES
PIRAMAL ENTERPRISES - LUPIN COMPARISON
COMPARE PIRAMAL ENTERPRISES WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.